CoChat

SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells

Open access
Bell, Robert D., Deane, Rashid, Chow, Nienwen, Long, Xiaochun, Sagare, Abhay, Singh, Itender, Streb, Jeffrey W., Guo, Huang, Rubio, Anna, Van Nostrand, William, Miano, Joseph M., Zlokovic, Berislav V. · 2009 · Nature Cell Biology

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Amyloid beta-peptide (Abeta) deposition in cerebral vessels contributes to cerebral amyloid angiopathy (CAA) in Alzheimer's disease (AD). Here, we report that in AD patients and two mouse models of AD, overexpression of serum response factor (SRF) and myocardin (MYOCD) in cerebral vascular smooth muscle cells (VSMCs) generates an Abeta non-clearing VSMC phenotype through transactivation of sterol regulatory element binding protein-2, which downregulates low density lipoprotein receptor-related protein-1, a key Abeta clearance receptor. Hypoxia stimulated SRF/MYOCD expression in human cerebral VSMCs and in animal models of AD. We suggest that SRF and MYOCD function as a transcriptional switch, controlling Abeta cerebrovascular clearance and progression of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncb1819

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. Holtzman, D. M. et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47, 739–747 (2000). · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8

Cited by

Items 201–262 of 262

Metadata

Authors
Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J. W., Guo, H., Rubio, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V.
Affiliations
University of Rochester Medicine (US)
Venue
Nature Cell Biology
Published
2008-12-21
Volume
11
Issue
2
Pages
143-153
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W2094117787
Cited by
261
References
52
Citations by year
2026: 5 · 2025: 10 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 10 · 2020: 9 · 2019: 12 · 2018: 6 · 2017: 19 · 2016: 12 · 2015: 19 · 2014: 20 · 2013: 17 · 2012: 29
FWCI
14.03
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Chinese Academy of Agricultural Sciences
  • National Institutes of Health
  • National Institute on Aging (R37AG023084, R42AG026950, 1R43 AG02400)
  • National Heart, Lung, and Blood Institute (R01HL132574, HL 62572, R01HL062572, R01HL091168)
  • National Institute of Neurological Disorders and Stroke (R37NS034467, R01NS034467, R37NS34467)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
serum response factor, myocardin, LRP1, amyloid-beta clearance, cerebral amyloid angiopathy, Alzheimer's disease, SREBP2, cerebral hypoxia, transcriptional regulation
MeSH terms
Myocardin, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Blood-Brain Barrier, Cells, Cultured, Cerebral Arteries, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Muscle, Smooth, Vascular, Nuclear Proteins, Transcriptional Activation, Trans-Activators, Down-Regulation, Amyloid beta-Peptides, Serum Response Factor, Low Density Lipoprotein Receptor-Related Protein-1, Mice, Sterol Regulatory Element Binding Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.